Drugmakers in India are hard at work engineering hepatitis C combination pills impossible in western nations due to patent protections.
New antiviral medications from Gilead Sciences Inc. and Bristol-Myers Squibb Co. have transformed the way hepatitis C is treated, making it a curable disease. Treatment regimens combining Bristol-Myers’ Daklinza with Gilead’s Sovaldi were approved by European authorities as effective against most strains of the hepatitis C virus, but a combination pill can’t be manufactured because the two companies haven’t collaborated on making one.
Help employers find you! Check out all the jobs and post your resume.
New antiviral medications from Gilead Sciences Inc. and Bristol-Myers Squibb Co. have transformed the way hepatitis C is treated, making it a curable disease. Treatment regimens combining Bristol-Myers’ Daklinza with Gilead’s Sovaldi were approved by European authorities as effective against most strains of the hepatitis C virus, but a combination pill can’t be manufactured because the two companies haven’t collaborated on making one.
Help employers find you! Check out all the jobs and post your resume.
